An evaluation and replication of miRNAs with disease stage and colorectal cancer‐specific mortality
Open Access
- 6 December 2014
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 137 (2) , 428-438
Abstract
MicroRNAs (miRNAs) have been implicated in colorectal cancer (CRC) development and associated with prognostic indicators such as disease stage and survival. Prognostic associations are often based on few individuals and imprecise. In this study, we utilize population‐based data from 1,141 CRC cases to replicate previously reported associations between 121 miRNAs and disease stage and survival. The Agilent Human miRNA Microarray V19.0 was used to generate miRNA data following a stringent quality control protocol. Assessment of survival was done using Cox Proportional Hazard models adjusting for age, disease stage and tumor molecular phenotype. Five miRNAs were associated with more advanced disease stage; hsa‐miR‐145‐5p and hsa‐miR‐31‐5p showed increased expression with more advanced tumor stage, while hsa‐miR‐200b‐3p, hsa‐miR‐215 and hsa‐miR‐451a had decreased expression with more advanced tumors. Thirteen miRNAs were associated with CRC mortality among individuals diagnosed with colon cancer while 14 were associated with CRC mortality after a diagnosis with rectal cancer. Strongest associations were observed for those miRNAs that were expressed in a small subset of tumors. Most notable associations were for hsa‐miR‐145‐3p [hazard ratio (HR) 2.94, 95% confidence interval (CI) 1.54, 5.61], and hsa‐miR‐9‐3p (HR 10.28, 95% CI 1.31, 80.84) with colon cancer and hsa‐miR‐335‐5p (HR 0.17, 95% CI 0.05, 0.54) for rectal cancer. hsa‐miR‐374a‐5p, hsa‐miR‐570‐3p and hsa‐miR‐18a‐5p significantly reduced the hazard of dying for all cases, regardless of tumor site. Our findings illustrate the need for a large sample to evaluate the association of miRNAs with survival and disease stage in order to determine associations by tumor site.Keywords
Funding Information
- National Cancer Institute (163683-02)
This publication has 51 references indexed in Scilit:
- Prognostic value of circulating microRNA-21 in digestive system cancers: a meta-analysis.2014
- miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent ProliferationMolecular Cancer Research, 2012
- Mutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancerProceedings of the National Academy of Sciences, 2011
- MicroRNAs and colon and rectal cancer: Differential expression by tumor location and subtypeGenes, Chromosomes and Cancer, 2010
- Pathogenetic and clinical relevance of microRNAs in colorectal cancer.2009
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Prognostic Values of microRNAs in Colorectal CancerBiomarker Insights, 2006
- miRBase: The MicroRNA Sequence Database2006
- Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of biasMutation Research/Mutation Research Genomics, 2000
- Energy balance and colon cancer--beyond physical activity.1997